Skip to main content
Fig. 7 | Journal of Translational Medicine

Fig. 7

From: OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma

Fig. 7

OKN-007 and LDN-193189 both decrease the human nuclear antigen (HNA) in a DIPG model. IHC post-mortem analysis at the completion of treatment, staining for HNA. a The ROI’s for data analysis of IHC were placed in the heavily stained regions of the pons as circled in red. b Cell stain positivity for anti-human nuclear antigen was significantly higher in the untreated mice compared to both treatment groups. No significant difference was seen between the two treatment arms. Sample legend: Untreated (UT)—closed circles (n = 4); OKN-007 (OKN)—open squares (n = 4); and LDN-193189 (LDN)—closed triangles (n-5). An ANOVA (one-way ANOVA, multiple comparisons) statistical test was used. ***p < 0.001, ****p < 0.0001, and ns is not significant. c The 20× view of IHC slides visibly show higher cell stain positivity and cellularity in the untreated mice compared to the d OKN-007 treated and e LDN-193189 treated mice. The scale bar in each image frame is 100 µm

Back to article page